MLNR/GPR38/Motilin Receptor Antibody (Cytoplasmic Domain)
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application ![]()
| IHC-P |
---|---|
Primary Accession | O43193 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 45kDa |
Dilution | IHC-P (1.1 µg/ml) |
Gene ID | 2862 |
---|---|
Other Names | Motilin receptor, G-protein coupled receptor 38, MLNR, GPR38, MTLR, MTLR1 |
Target/Specificity | Human MLNR. BLAST analysis of the peptide immunogen showed no homology with other human proteins. |
Reconstitution & Storage | Long term: -70°C; Short term: +4°C |
Precautions | MLNR/GPR38/Motilin Receptor Antibody (Cytoplasmic Domain) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | MLNR |
---|---|
Synonyms | GPR38, MTLR, MTLR1 |
Function | Receptor for motilin. |
Cellular Location | Cell membrane; Multi-pass membrane protein. |
Tissue Location | Expressed only in thyroid, stomach, and bone marrow |
Volume | 50 µl |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Receptor for motilin.
References
McKee K.K.,et al.Genomics 46:426-434(1997).
Feighner S.D.,et al.Science 284:2184-2188(1999).
King M.M.,et al.Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
Dunham A.,et al.Nature 428:522-528(2004).
Smith R.G.,et al.Endocrine 14:9-14(2001).

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.